On March 21, Evelina Mikaelson, CEO, presents the latest developments in the company at Redeye. The presentation is live broadcasted and can be followed at https://www.redeye.se/events/869691/innovative-orthopedic-2 where the replay and the presentations will be available afterwards.
For more information, please contact:
CEO Biomedical Bonding AB
Phone: +46 763 422 824
About Biomedical Bonding AB
Biomedical Bonding AB is a Swedish MedTech company that develops cutting-edge medical adhesive fixators and novel surgical methodologies with focus on the ever-growing market of hard tissue restorations. The technological platform, Bonevolent™, is market disruptive and stands for a paradigm shift in personalized surgical interventions. BMB´s vision is to become the dominant global provider of unique adhesive products suited for fracture fixation and dental restoration market. BMB´s Bonevolent™ products are easy-to-use by clinicians, will increase patient safety, save costs and resources for health care and society as a whole. BMB is a privately held company headquartered in Stockholm, Sweden.